Evidence map›Paper›PMID 41054507›Full record

ArticleiScience2025

Characterization of human CD34

Steven D S Webbers, Angela A F Gankema, Fleur van Oosterom, Felipe Rojas-Rodriguez, Dané S Koops, Anna K Klaus, Judy Geissler, Teunis J P van Dam, Hanke L Matlung, Robin van Bruggen and 3 more

Abstract read
In one paragraph

Article in iScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Steven D S WebbersDepartment of Molecular Hematology, Sanquin Research, University of Amsterdam, 1066 CX Amsterdam, the Netherlands.
Angela A F GankemaDepartment of Molecular Hematology, Sanquin Research, University of Amsterdam, 1066 CX Amsterdam, the Netherlands.
Fleur van OosteromDepartment of Molecular Hematology, Sanquin Research, University of Amsterdam, 1066 CX Amsterdam, the Netherlands.
Felipe Rojas-RodriguezDepartment of Molecular Hematology, Sanquin Research, University of Amsterdam, 1066 CX Amsterdam, the Netherlands.
Dané S KoopsDepartment of Molecular Hematology, Sanquin Research, University of Amsterdam, 1066 CX Amsterdam, the Netherlands.
Anna K KlausDepartment of Molecular Hematology, Sanquin Research, University of Amsterdam, 1066 CX Amsterdam, the Netherlands.
Judy GeisslerDepartment of Molecular Hematology, Sanquin Research, University of Amsterdam, 1066 CX Amsterdam, the Netherlands.
Teunis J P van DamDepartment of Molecular Hematology, Sanquin Research, University of Amsterdam, 1066 CX Amsterdam, the Netherlands.
Hanke L MatlungDepartment of Molecular Hematology, Sanquin Research, University of Amsterdam, 1066 CX Amsterdam, the Netherlands.
Robin van BruggenDepartment of Molecular Hematology, Sanquin Research, University of Amsterdam, 1066 CX Amsterdam, the Netherlands.
Helin TercanDepartment of Molecular Hematology, Sanquin Research, University of Amsterdam, 1066 CX Amsterdam, the Netherlands.
Arie J HoogendijkDepartment of Molecular Hematology, Sanquin Research, University of Amsterdam, 1066 CX Amsterdam, the Netherlands.
Taco W KuijpersDepartment of Molecular Hematology, Sanquin Research, University of Amsterdam, 1066 CX Amsterdam, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neutrophils have limited utility as a fundamental research model and transfusion product due to their short lifespan. Here, we cultured CD34

Indexed as

ImmunologyProteomicsTranscriptomics

Identifiers

PMID41054507
PMCPMC12496184

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.